<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362674">
  <stage>Registered</stage>
  <submitdate>21/06/2012</submitdate>
  <approvaldate>25/06/2012</approvaldate>
  <actrnumber>ACTRN12612000679886</actrnumber>
  <trial_identification>
    <studytitle>In pregnant women how accurate are haemoglobin levels, when measured by two devices Pronto 7 Pulse CO-Oximeter 'Registered Trademark' and Hemocue 'Registered Trademark', compared to the laboratory</studytitle>
    <scientifictitle>In Pregnant women, agreement between haemoglobin measured by three techniques: the laboratory, non-invasive spectrophotometry (Pronto 7 Pulse CO- Oximeter, Masimo Corp, Irvine USA) &amp; invasive photometry absorbance (HemoCue, Angelholm, Sweden), a method comparison study.</scientifictitle>
    <utrn>U1111-1132-0178</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Haemoglobin measurement</healthcondition>
    <healthcondition>Pregnancy</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Normal pregnancy</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Blood</conditioncode1>
      <conditioncode2>Other blood disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Measurement of haemoglobin concentration in pregnant women assessed for each women at a single time point between 20  weeks gestation and the immediate postpartum period.
In each women three measurement techniques will be used (i) automated laboratory, (ii) non-invasive spectrophotometry (Pronto 7 Pulse CO- Oximeter, Masimo Corp, Irvine USA) &amp; (iii) invasive photometry absorbance (HemoCue, Angelholm, Sweden). 
Techniques (i) &amp; (iii) will  use a venous blood sample, whilst (ii) uses a transcutaneous probe placed on the patients finger.</interventions>
    <comparator>Uncontrolled</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Agreement (precision, fixed and proportional bias)</outcome>
      <timepoint>at single point in time in women between 20 weeks gestation and 5 days post-partum.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Greater than 20 weeks gestation
Having routine Full Blood examination</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>none</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Convenience sample</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/07/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>3084</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Richard Hiscock</primarysponsorname>
    <primarysponsoraddress>Mercy Hospital For Women
163 Studley Road
Heidelberg Vic 3084</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Anaesthetic Department, Mercy Hospital For Women</fundingname>
      <fundingaddress>Mercy Hospital For Women
163 Studley Road
Heidelberg Vic 3084</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Scott Simmons</sponsorname>
      <sponsoraddress>Mercy Hospital For Women
163 Studley Road
Heidelberg Vic 3084</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Individual</othercollaboratortype>
      <othercollaboratorname>Dr Grace Seow</othercollaboratorname>
      <othercollaboratoraddress>Mercy Hospital For Women
163 Studley Road
Heidelberg Vic 3084</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study aims to assess the agreement between the  laboratory measurement of blood haemoglobin and that obtained from two devices which measure haemoglobin at the patients bedside thus providing rapid results which can be used to guide management. One is the HemoCue 'Registered Trademark' device measures Hb concentration from very small amounts of blood either from a finger prick or the veins, the other is the Masimo Pronto-7 'Registered Trademark' spectrophotometry device measures Hb concentration non-invasively using light sensors on a finger probe similar to those used to measure the amount of oxygen in the blood.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Mercy Hospital For women</ethicname>
      <ethicaddress>Mercy Hospital For Women
163 Studley Road
Heidelberg Vic 3084</ethicaddress>
      <ethicapprovaldate>6/12/2011</ethicapprovaldate>
      <hrec>R11/66</hrec>
      <ethicsubmitdate>6/11/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Richard Hiscock</name>
      <address>Mercy Hospital For Women
163 Studley Road 
Heidelberg Vic  3084</address>
      <phone>+61 3 84584113</phone>
      <fax />
      <email>rhiscock@mercy.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Richard Hiscock</name>
      <address>Mercy Hospital For Women
163 Studley Road 
Heidelberg Vic 3084</address>
      <phone>+61 3 84584113</phone>
      <fax />
      <email>rhiscock@mercy.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Richard Hiscock</name>
      <address>Mercy Hospital For Women
163 Studley Road 
Heidelberg Vic 3084</address>
      <phone>+61 3 84584113</phone>
      <fax />
      <email>rhiscock@netspace.net.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>